|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 166.70 INR | -0.98% |
|
+0.79% | -29.36% |
| 14/02 | Thirumalai Chemicals Limited Announces Management Changes | CI |
| 14/02 | Thirumalai Chemicals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 | CI |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.09TCr | 2TCr | 2.13TCr | 2.08TCr | 2.05TCr | |||||
Total Revenues | 1.09TCr | 2TCr | 2.13TCr | 2.08TCr | 2.05TCr | |||||
Cost of Goods Sold, Total | 664.15Cr | 1.23TCr | 1.57TCr | 1.7TCr | 1.63TCr | |||||
Gross Profit | 421.59Cr | 772.31Cr | 559.63Cr | 380.74Cr | 419.19Cr | |||||
Selling General & Admin Expenses, Total | 55Cr | 77Cr | 82Cr | 84Cr | 96Cr | |||||
Depreciation & Amortization - (IS) | 50Cr | 57Cr | 56Cr | 63Cr | 61Cr | |||||
Other Operating Expenses | 144.75Cr | 251.5Cr | 290.28Cr | 239.79Cr | 270.83Cr | |||||
Other Operating Expenses, Total | 249.66Cr | 384.66Cr | 428.36Cr | 386.51Cr | 427.78Cr | |||||
Operating Income | 171.93Cr | 387.65Cr | 131.27Cr | -5.77Cr | -8.59Cr | |||||
Interest Expense, Total | -18Cr | -17Cr | -26Cr | -36Cr | -44Cr | |||||
Interest And Investment Income | 4.64Cr | 8.48Cr | 20Cr | 18Cr | 10Cr | |||||
Net Interest Expenses | -13Cr | -8.43Cr | -6.31Cr | -18Cr | -34Cr | |||||
Currency Exchange Gains (Loss) | -18L | -1.19Cr | 7.87Cr | -5.48Cr | 2.43Cr | |||||
Other Non Operating Income (Expenses) | -2.39Cr | -2.76Cr | -4.47Cr | -5.65Cr | -4.22Cr | |||||
EBT, Excl. Unusual Items | 156.2Cr | 375.27Cr | 128.36Cr | -35Cr | -45Cr | |||||
Gain (Loss) On Sale Of Investments | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | 7L | - | 11L | 5L | 1.49Cr | |||||
Asset Writedown | - | - | - | - | - | |||||
Insurance Settlements | 86L | 10L | 94L | 32L | 1.92Cr | |||||
Other Unusual Items | - | - | - | - | 45L | |||||
EBT, Incl. Unusual Items | 157.13Cr | 375.37Cr | 129.41Cr | -35Cr | -41Cr | |||||
Income Tax Expense | 39Cr | 94Cr | 40Cr | 4.24Cr | 5.25Cr | |||||
Earnings From Continuing Operations | 117.69Cr | 281.23Cr | 90Cr | -39Cr | -46Cr | |||||
Net Income to Company | 117.69Cr | 281.23Cr | 90Cr | -39Cr | -46Cr | |||||
Net Income - (IS) | 117.69Cr | 281.23Cr | 90Cr | -39Cr | -46Cr | |||||
Net Income to Common Incl Extra Items | 117.69Cr | 281.23Cr | 90Cr | -39Cr | -46Cr | |||||
Net Income to Common Excl. Extra Items | 117.69Cr | 281.23Cr | 90Cr | -39Cr | -46Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 11.49 | 27.47 | 8.77 | -3.79 | -4.5 | |||||
Basic EPS - Continuing Operations | 11.49 | 27.47 | 8.77 | -3.79 | -4.5 | |||||
Basic Weighted Average Shares Outstanding | 10Cr | 10Cr | 10Cr | 10Cr | 10Cr | |||||
Net EPS - Diluted | 11.49 | 27.47 | 8.77 | -3.79 | -4.5 | |||||
Diluted EPS - Continuing Operations | 11.49 | 27.47 | 8.77 | -3.79 | -4.5 | |||||
Diluted Weighted Average Shares Outstanding | 10Cr | 10Cr | 10Cr | 10Cr | 10Cr | |||||
Normalized Basic EPS | 9.53 | 22.91 | 7.84 | -2.13 | -2.73 | |||||
Normalized Diluted EPS | 9.53 | 22.91 | 7.84 | -2.13 | -2.73 | |||||
Dividend Per Share | 2.2 | 2.5 | 1.5 | 1 | - | |||||
Payout Ratio | - | 7.94 | 28.5 | -39.6 | -22.21 | |||||
Supplemental Items | ||||||||||
EBITDA | 220.73Cr | 441.44Cr | 182.55Cr | 51Cr | 47Cr | |||||
EBITA | 171.93Cr | 387.65Cr | 131.27Cr | -5.77Cr | -8.59Cr | |||||
EBIT | 171.93Cr | 387.65Cr | 131.27Cr | -5.77Cr | -8.59Cr | |||||
EBITDAR | 222.74Cr | 443.84Cr | 186.23Cr | 54Cr | 54Cr | |||||
Total Revenues (As Reported) | 1.09TCr | 2.01TCr | 2.16TCr | 2.1TCr | 2.07TCr | |||||
Effective Tax Rate - (Ratio) | 25.1 | 25.08 | 30.58 | -12.27 | -12.85 | |||||
Total Current Taxes | 41Cr | 92Cr | 38Cr | 11Cr | 22Cr | |||||
Total Deferred Taxes | -1.23Cr | 2.06Cr | 1.68Cr | -6.81Cr | -17Cr | |||||
Normalized Net Income | 98Cr | 234.54Cr | 80Cr | -22Cr | -28Cr | |||||
Interest Capitalized | 1.94Cr | 30L | 6Cr | 56Cr | 62Cr | |||||
Interest on Long-Term Debt | 23Cr | 21Cr | 37Cr | 61Cr | 67Cr | |||||
Non-Cash Pension Expense | 50L | 57L | 66L | 81L | 89L | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 2.9Cr | 2.64Cr | 2.53Cr | 2.47Cr | 1.91Cr | |||||
Net Rental Expense, Total | 2.01Cr | 2.4Cr | 3.68Cr | 3.7Cr | 7.38Cr | |||||
Imputed Operating Lease Interest Expense | 1.67Cr | 1.9Cr | 2.79Cr | 3.09Cr | 4.14Cr | |||||
Imputed Operating Lease Depreciation | 33.85L | 49.97L | 88.81L | 60.88L | 3.24Cr | |||||
Maintenance & Repair Expenses, Total | 15Cr | 28Cr | 41Cr | 38Cr | 44Cr |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















